Development of Kinase-Selective, Harmine-Based DYRK1A Inhibitors that Induce Pancreatic Human β-Cell Proliferation.
Development of Kinase-Selective, Harmine-Based DYRK1A Inhibitors that Induce Pancreatic Human β-Cell Proliferation.
复制标题
DOI:
10.1021/acs.jmedchem.8b00658
复制
发表时间:
2018-09-13
影响因子:
7.3
通讯作者:
DeVita RJ
中科院分区:
文献类型:
--
作者:
Kumar K;Wang P;Sanchez R;Swartz EA;Stewart AF;DeVita RJ
DYRK1A has been implicated as an important drug target in various therapeutic areas, including neurological disorders and oncology. DYRK1A has more recently been shown to be involved in pathways regulating human β-cell proliferation, thus making it a potential therapeutic target for both Type 1 and Type 2 diabetes. Our group, using a high-throughput phenotypic screen, identified harmine that is able to induce β-cell proliferation both in vitro and in vivo. Since harmine has suboptimal kinase selectivity, we sought to expand structure−activity relationships for harmine’s DYRK1A activity, to enhance selectivity, while retaining human β-cell proliferation capability. We carried out the optimization of the 1-position of harmine and synthesized 15 harmine analogues. Six compounds showed excellent DYRK1A inhibition with IC50 in the range of 49.5–264 nM. Two compounds, 2–2 and 2–8, exhibited excellent human β-cell proliferation at doses of 3–30 μM, and compound 2–2 showed improved kinase selectivity as compared to harmine.
登录
查看更多内容
影响因子:
4.7
作者:
Coutadeur, Severine;Benyamine, Helene;Desire, Laurent
通讯作者:
Desire, Laurent
影响因子:
3.4
作者:
Balint, Balazs;Weber, Csaba;Kotschy, Andras
通讯作者:
Kotschy, Andras
影响因子:
3.5
作者:
Akue-Gedu, Rufine;Debiton, Eric;Moreau, Pascale
通讯作者:
Moreau, Pascale
影响因子:
3
作者:
Becker, Walter;Soppa, Ulf;Tejedor, Francisco J.
通讯作者:
Tejedor, Francisco J.
DOI:
10.1016/s1499-3872(11)60102-1
发表时间:
2011-12-01
影响因子:
3.3
作者:
Cao, Ming-Rong;Li, Qiang;Jiang, Jian-Wei
通讯作者:
Jiang, Jian-Wei